US20150086943A1 - Two-part implant with a hydroxylated soft tissue contact surface - Google Patents
Two-part implant with a hydroxylated soft tissue contact surface Download PDFInfo
- Publication number
- US20150086943A1 US20150086943A1 US14/474,604 US201414474604A US2015086943A1 US 20150086943 A1 US20150086943 A1 US 20150086943A1 US 201414474604 A US201414474604 A US 201414474604A US 2015086943 A1 US2015086943 A1 US 2015086943A1
- Authority
- US
- United States
- Prior art keywords
- contact surface
- soft tissue
- tissue contact
- anchor part
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0009—Consolidating prostheses or implants, e.g. by means of stabilising pins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
- A61C8/0015—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating being a conversion layer, e.g. oxide layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0048—Connecting the upper structure to the implant, e.g. bridging bars
- A61C8/005—Connecting devices for joining an upper structure with an implant member, e.g. spacers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0093—Features of implants not otherwise provided for
-
- A61K6/0023—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/50—Containers, packaging elements or packages, specially adapted for particular articles or materials for living organisms, articles or materials sensitive to changes of environment or atmospheric conditions, e.g. land animals, birds, fish, water plants, non-aquatic plants, flower bulbs, cut flowers or foliage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
- A61C8/0037—Details of the shape
- A61C2008/0046—Textured surface, e.g. roughness, microstructure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
Definitions
- the present invention relates to a two-stage implant comprising a base body having a bone contact surface and a tissue contact surface and to a method for preparing such an implant.
- Implants which are used for insertion into bone, for example for attachment of artificial teeth are known per se.
- Different types of implant systems are known, for example two-part implant systems.
- Said two-part implant systems comprise first an anchoring part for anchoring within the bone and second a mounting part.
- Onto the mounting part prosthesis elements, such as bridges or crowns, are screwed or cemented usually using intermediate so-called abutments.
- a central property of said implants is their osteointegration time, that is to say the time that passes before the bone substance has become connected with sufficient strength and permanently to the bone contact surface, that is to say it has become integrated with it.
- US 2004/0049287 discloses an endosseous implant, said implant having a surface made from metal or ceramic.
- the surface has a smooth or rough texture and has been treated with at least one pharmaceutically acceptable organic compound carrying at least one phosphonic acid group. Said implants showed an improved bone bonding strength.
- U.S. Pat. No. 5,397,362 discloses an implant prosthesis comprising a substrate of a ceramic material, a glass layer coated over the adhering interface of the substrate and a thermally sprayed layer of calcium phosphate based material formed over the glass layer.
- WO 2005/120386 discloses a dental implant comprising an anchoring element for anchoring the dental implant in the bone and an abutment for fastening a crown or the like suprastructure.
- the anchoring element and the abutment are produced from zirconium oxide.
- the supracrestal connective tissue plays a fundamental role in establishing an effective seal between the oral environment and the endosseous part of a dental implant.
- the presence of bacteria on the implant surface may lead to an inflammation of the peri-implant mucosa, and, if left untreated, the inflammation spreads apically and results in bone resorption.
- the soft tissue contact surface of the implants is highly polished (see Oral Implantology, Thieme Verlag, 1996, page 438).
- An implant according to the invention comprises a base body having a bone contact surface and a soft tissue contact surface, wherein the soft tissue contact surface is at least partially hydroxylated or silanated. Said soft tissue contact surface has the potential to promote formation of soft tissue attachment.
- the implant according to the present invention leads to the formation of new connective tissue adjacent to the soft tissue contact surface of the implant and the new connective tissue tends to be in close contact with the soft tissue contact surface of the implant.
- the loose connective tissue seems to become organized and replaced be newly formed collagen fibers, originating from its outer zone. These fibers tend to be organized in a perpendicular way towards the soft tissue contact surface, similarly to the naturally occurring fibers most responsible for compensation forces on the tooth.
- An implant in terms of the present invention is intended to mean the anchor part of a two-part implant system, that is that part which becomes integrated with the bone.
- the anchoring part of said two-part implant system may be inserted in a one-stage or a two-stage procedure.
- Said anchoring part is sunk in up to about 1.5-3 mm above the bone ridge at mucosal level.
- Said anchor part has a bone contact surface meaning the part which is in contact with the bone.
- the top of the anchoring part which is in contact with the soft tissue is defined as the soft tissue contact surface.
- “Hydroxylated” in terms of the present invention means hydroxyl groups which are present in the outermost atomic layer of the implant surface. If the implant comprises titanium, zirconium, tantalum, niobium, hafnium or alloys thereof as well as chemically similarly reacting alloys, it is assumed that the surface of metal oxidizes spontaneously in air and water and that a reaction then takes place with water on the surface to form hydroxyl groups. This surface containing hydroxyl groups is referred to in the literature as a “hydroxylated” surface; cf. H. P. Boehm, Acidic and Basic Properties of Hydroxylated Metal Oxide Surfaces, Discussions Faraday Society, vol. 52, 1971, pp. 264-275.
- Silanated in terms of the present invention means that the implant surface is covered by a silanole or by an organo silane compound which has at least one free hydroxyl group.
- organo silane compounds are X n SiR 4-n , wherein X is selected from the group consisting of Cl, Br, I, F or OR, and R is selected from the group of lower alkyl groups, such as methyl, ethyl, propyl etc.
- Implants made of metal are preferably covered by a silanole, whereas implants made of ceramic are preferably covered by an organo silane compound. Implants made of metal can also be covered by an organo silan compound, and implants made of ceramic can also be covered by silanole.
- the soft tissue contact surface is completely hydroxylated.
- Such an implant showed good results in vivo and said implants are economically interesting and can be produced in a controlled process.
- the healing process is improved, that is a good osteointegration as well as an excellent soft tissue integration is achieved. Therefore, the implants comprise a reduced risk of periimplantitis and as a consequence fewer implants will have to be replaced.
- the soft tissue contact surface is roughened and hydroxylated.
- a roughened surface in terms of the present invention means a macroscopic texture of the surface which is obtained for example by sandblasting the soft tissue contact surface. It has been found that if the soft tissue contact surface is roughened and hydroxylated the blood coagulum is stabilized which accelerates the healing procedure.
- the soft tissue contact surface is smooth but hydroxylated.
- a smooth surface in terms of the present invention means a macroscopic texture of the surface which is obtained for example by machining or additional polishing, preferably by electropolishing the soft tissue contact surface. With a smooth surface the accumulation of plaque can be prevented or at least minimized, and such a soft tissue contact surface has outstanding wettability properties which is highly preferred.
- the bone contact surface and the soft tissue surface of the implant are both roughened, hydroxylated and hydrophilic or alternatively both smooth, hydroxylated and hydrophilic.
- Such implants are particularly easy to produce since the entire implant can be treated in the same way. This is a very big advantage and is based on the surprising finding that a hydroxylated, hydrophilic and roughened soft tissue surface of the implant shows improved soft tissue integration.
- the soft tissue contact surface is hydrophilic.
- the soft tissue contact surface is referred to as “hydrophilic” if it is freely accessible to the body fluid and not covered with foreign substances, for example substances with a hydrophobic action.
- Various volatile hydrocarbons are conventionally present in non-purified air. These are rapidly adsorbed in a thin layer by hydroxylated and hydrophilic surfaces, whereby such surfaces are no longer hydrophilic.
- a hydroxylated and hydrophilic surface can become hydrophobic if the hydroxyl groups present on the surface associate or react chemically e.g. with carbon dioxide present in the air or with organic solvents, such as methanol or acetone, introduced via the cleaning process.
- the hydrophilic properties of the soft tissue contact surface may result in a higher wettability when compared to an untreated soft tissue contact surface, which promotes formation of the soft tissue. Further, the charge on the surface is better available which may accelerate the formation of soft tissue attachment as well.
- the implants according to the invention preferably comprise mainly a metal selected from the group consisting of titanium, zirconium, niobium, hafnium or tantalum, preferably titanium or zirconium.
- the implants comprise an alloy of metals selected from the group consisting of titanium, zirconium, niobium, hafnium or tantalum, preferably a binary titanium/zirconium alloy.
- Such implants, their nature and the metal materials used to produce them are known per se and are described for example in J. Black, G. Hastings, Handbook of Biomaterials Properties, pages 135-200, published by Chapman & Hall, London, 1998. From an aesthetic point of view, in particular in the front visible region, the soft tissue contact surface is preferably covered with a ceramic coating.
- EP 1 566 152 describes the coating of a dental implant with zirconia.
- the implants may comprise a ceramic ring element, in particular in the soft tissue contact surface.
- Such ceramic coatings and ring elements comprise typically zirconia, aluminia, silica or mixtures thereof with possible further constituents, preferably they are made of zirconia.
- the implant according to the present invention may be made of ceramic.
- the implant according to the present invention is made of ceramic comprising a zirconium oxide based material.
- the cubic structure of zirconium oxide may be stabilized by metallic oxides at room temperature.
- Preferred metallic oxides are magnesium oxide, calcium oxide, oxides of the lanthanide group, preferably yttrium oxide.
- the cubic high temperature phase of zirconia can be stabilized fully or partly at room temperature (cubic stabilized zirconium oxide).
- zirconia is stabilized by yttrium oxide.
- the present invention also relates to the process for preparing the above disclosed implant.
- the soft tissue contact surface of the implant is preferably etched with an inorganic acid, an inorganic base, a mixture of inorganic bases or a mixture of inorganic acids.
- inorganic acids such as hydrofluoric acid, hydrochloric acid, sulfuric acid, nitric acid or a mixture of such acids.
- the implant is etched with a mixture of hydrochloric acid (conc.), sulphuric acid (conc.) and water in a weight ration of about 2:1:1.
- the surface is activated with hydrochloric acid (conc.), hydrogen peroxide (conc.) and water in a weight ratio of about 1:1:5.
- the soft tissue contact surface is then washed with pure water in an inert atmosphere.
- a roughened soft tissue contact surface can be obtained by sandblasting said surface and keeping the surface in the resulting state if it is already hydroxylated and hydrophilic or converting the sandblasted surface to a hydroxylated and hydrophilic state in a separate process step.
- the roughened soft tissue contact surface can be produced by shot peening or sandblasting said surface and/or roughening it by using plasma technology, and then treating the mechanically roughened surface by an electrolytic or chemical process until a hydroxylated and hydrophilic surface is formed.
- the implant is not subjected to further aftertreatment, i.e. it is not treated with alcohol, acetone or any other organic solvent.
- said pure water contains neither carbon dioxide nor hydrocarbon vapours and especially no acetone and no alcohols like methanol or ethanol.
- it can contain special additives as described below.
- the “pure” water used for washing has preferably been distilled several times or prepared by reverse osmosis; the water has preferably been prepared in an inert atmosphere, i.e. under reduced pressure in a nitrogen or noble gas atmosphere, for example.
- the implant 1 obtained is left in pure water and stored in a closed vessel or a covering 2 , as shown in FIG. 2 .
- the interior of the covering can contain inert gases 3 , for example nitrogen, oxygen or a noble gas such as argon.
- the implant obtained is preferably stored in pure water optionally containing selective additives, and in a covering which is practically impermeable to gases and liquids, especially to carbon oxides, the interior of the covering being devoid of any compounds capable of impairing the activity of the implant surface.
- the implant could be placed in an inert gas atmosphere.
- the implant according to the invention is preferably sealed in a gas-tight and liquid-tight covering, the interior of the covering being devoid of any compounds capable of impairing the biological activity of the implant surface. In this way it is avoided that the surface loses its activation fully or partially by means of air constituents, before the dental implant is applied.
- This gas-tight and liquid-tight covering is preferably a heat-sealed ampoule made of glass, metal, a synthetic polymer or some other gas-tight and liquid-tight material, or a combination of these materials.
- the metal preferably takes the form of a thin sheet, it being possible for polymeric materials and metal sheets, as well as glass, to be combined together to form a suitable packaging in a manner known per se.
- Suitable additives which can be incorporated in the pure water are cations and anions which already occur in the body fluid.
- the implant according to the present invention is preferably stored at a pH ranging from pH 3 to 7, preferably 4 to 6.
- the implant is also possible to store the implant at a pH ranging from pH 7 to 10 in order to stabilize the negative charge.
- Preferred cations are Na + , K + , Mg 2+ and Ca 2+ .
- the preferred anion is Cl ⁇ .
- the total amount of said cations or anions ranges preferably from about 50 mM to 250 mM, particularly preferably from about 100 mM to 200 mM, and is preferably about 150 mM.
- the covering contains divalent cations, especially Mg 2+ , Ca 2+ , Sr 2+ and/or Mn 2+ , on their own or in combination with the above-mentioned monovalent cations, the total amount of divalent cations present preferably ranges from 1 mM to 20 mM.
- FIG. 1 shows the different areas of an embodiment of an implant according to the invention that is the anchoring part of a two-part implant system.
- FIG. 2 shows an implant system according to the invention.
- FIG. 1 shows an implant 1 which is preferably made of a tissue compatible metal or of an alloy of such a metal, in particular of titanium or of a titanium alloy.
- the implant is made of ceramic, preferably of zirconia. Further it is possible that parts of the implant are made of metal and parts of the implant are made of ceramic, for example if the inner part is made of titanium and the outer part of the implant is made of ceramic.
- the implant 1 has a threaded section 10 and a rounded lower end 15 . At its upper end it has a slightly enlarged conical section 20 . Said implant 1 is subdivided into a bone contact surface B and a soft tissue contact surface S.
- transition area B/S from bone contact surface B to soft tissue contact surface S, which transition area is assigned to both aforementioned areas.
- the question of whether this area, in the implanted state, is located in the bone or in the soft tissue depends on a large number of factors, for example the depth to which the implant is screwed, the tissue reaction, etc.
- the transition area has to be treated in the same way as the bone contact surface, in order to make sure, that in any case an optimal osteointegration is ensured.
- the bone contact surface is preferably roughened, and even more preferred hydroxylated and hydrophilic as well.
- the soft tissue contact surface S is at least partially, preferably completely hydroxylated.
- the soft tissue contact surface of an implant according to the present invention may be made of titanium, zirconium, tantalum, niobium, hafnium or alloys thereof as well as chemically similarly reacting alloys, but it is also possible that the implant has a ceramic coating which is hydroxylated.
- a common shape of dental implant in the form of a screw of diameter 4 mm and length 10 mm was produced.
- the crude shape was obtained in a manner known per se by removing material from the cylindrical blank by turning on a lathe and milling.
- the bone contact surface as well as the soft tissue surface were then sandblasted with particles having a mean size of 0.25-0.5 mm as described in EP 0 388 575.
- the roughened surface was then treated for about five minutes at a temperature above 80° C. with an aqueous hydrochloric acid (conc.)/sulfuric acid (conc.) mixture having an HCl:H 2 SO 4 :H 2 O ratio of 2:1:1.
- the implant formed in this way was washed with pure water and then heat-sealed directly in a glass ampoule filled with pure water containing 150 mM Na + ions, and the corresponding amount of Cl ⁇ anions.
- the above implants were placed in four female fox hounds. Each animal received 6 implants bilaterally in the upper jaw and 10 implants bilaterally in the lower jaw.
- the implants with a roughened hydroxylated soft tissue contact surface showed unexpectedly a much better soft tissue integration than comparable implants with an unhydroxylated surface.
- Soft tissue adhesion was seen already after a few days, the soft tissue integration was apparent within two weeks.
- a common shape of dental implant in the form of a screw of diameter 4 mm and length 10 mm was produced.
- the crude shape was obtained in a manner known per se by removing material from the cylindrical blank by turning on a lathe and milling.
- the bone contact surface was then sandblasted with particles having a mean size of 0.25-0.5 mm, whereas the soft tissue contact surface has been electropolished.
- the sandblasted bone contact surface as well as the electropolished soft tissue contact surface were then treated for about five minutes at a temperature above 80° C. with an aqueous hydrochloric acid (conc.)/sulfuric acid (conc.) mixture having an HCl:H 2 SO 4 :H 2 O ratio of 2:1:1.
- the implant formed in this way was washed with pure water and then heat-sealed directly in a glass ampoule filled with pure water containing 150 mM Na + ions, and the corresponding amount of Cl ⁇ anions.
- the above implants were placed in four female fox hounds. Each animal received 6 implants bilaterally in the upper jaw and 10 implants bilaterally in the lower jaw.
- the implants with a smooth hydroxylated soft tissue contact surface showed unexpectedly a much better soft tissue integration than comparable implants with an unhydroxylated surface.
- Soft tissue adhesion was seen already after a few days, the soft tissue integration was apparent within two weeks.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dentistry (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Evolutionary Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Mechanical Engineering (AREA)
- Dental Prosthetics (AREA)
- Materials For Medical Uses (AREA)
Abstract
Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.
Description
- This application is a divisional of and claims priority under 35 U.S.C. §120 to U.S. Ser. No. 11/680,055, filed Feb. 28, 2007, which claims priority to European Application No. 06004063.1, filed Feb. 28, 2006, the disclosures of which are incorporated herein in their entirety by reference.
- The present invention relates to a two-stage implant comprising a base body having a bone contact surface and a tissue contact surface and to a method for preparing such an implant.
- Implants which are used for insertion into bone, for example for attachment of artificial teeth, are known per se. Different types of implant systems are known, for example two-part implant systems. Said two-part implant systems comprise first an anchoring part for anchoring within the bone and second a mounting part. Onto the mounting part prosthesis elements, such as bridges or crowns, are screwed or cemented usually using intermediate so-called abutments.
- A central property of said implants is their osteointegration time, that is to say the time that passes before the bone substance has become connected with sufficient strength and permanently to the bone contact surface, that is to say it has become integrated with it.
- Therefore, much effort has been made in order to improve the osteointegration of said implants, such as described in
EP 1 150 620. It was shown that the osteointegration time was significantly shorter if the bone contact surface of the implant is roughened, hydroxylated and hydrophilic. - US 2004/0049287 discloses an endosseous implant, said implant having a surface made from metal or ceramic. The surface has a smooth or rough texture and has been treated with at least one pharmaceutically acceptable organic compound carrying at least one phosphonic acid group. Said implants showed an improved bone bonding strength.
- U.S. Pat. No. 5,397,362 discloses an implant prosthesis comprising a substrate of a ceramic material, a glass layer coated over the adhering interface of the substrate and a thermally sprayed layer of calcium phosphate based material formed over the glass layer.
- WO 2005/120386 discloses a dental implant comprising an anchoring element for anchoring the dental implant in the bone and an abutment for fastening a crown or the like suprastructure. The anchoring element and the abutment are produced from zirconium oxide.
- However, there is considerable evidence supporting the view that the supracrestal connective tissue plays a fundamental role in establishing an effective seal between the oral environment and the endosseous part of a dental implant. Indeed, the presence of bacteria on the implant surface may lead to an inflammation of the peri-implant mucosa, and, if left untreated, the inflammation spreads apically and results in bone resorption. As a consequence of the fact that rough surfaces accumulate and retain more plaque than smooth surfaces, nowadays, the soft tissue contact surface of the implants is highly polished (see Oral Implantology, Thieme Verlag, 1996, page 438).
- Various experiments have been carried out to investigate the difference of early inflammatory response to mucosa-penetrating implants prepared with varying surface roughness. Despite the fact that a rough surface may accumulate greater amounts of plaque than a smooth surface, no relation was found between inflammatory response and implant surface roughness (Wennerberg et al, J. Clin. Periodontol 2003: 30: 88-94; Quirynen et al, The International Journal of Oral and Maxillofacial Implants, 11, No. 2, 1996).
- It is the problem of the present invention to provide an implant with improved soft tissue integration.
- An implant according to the invention comprises a base body having a bone contact surface and a soft tissue contact surface, wherein the soft tissue contact surface is at least partially hydroxylated or silanated. Said soft tissue contact surface has the potential to promote formation of soft tissue attachment. In contrast to conventional implants having a roughened, in same cases also hydroxylated bone contact surface and a smooth unhydroxylated tissue contact surface, the implant according to the present invention leads to the formation of new connective tissue adjacent to the soft tissue contact surface of the implant and the new connective tissue tends to be in close contact with the soft tissue contact surface of the implant. The loose connective tissue seems to become organized and replaced be newly formed collagen fibers, originating from its outer zone. These fibers tend to be organized in a perpendicular way towards the soft tissue contact surface, similarly to the naturally occurring fibers most responsible for compensation forces on the tooth.
- An implant in terms of the present invention is intended to mean the anchor part of a two-part implant system, that is that part which becomes integrated with the bone. The anchoring part of said two-part implant system may be inserted in a one-stage or a two-stage procedure. Said anchoring part is sunk in up to about 1.5-3 mm above the bone ridge at mucosal level. Said anchor part has a bone contact surface meaning the part which is in contact with the bone. The top of the anchoring part which is in contact with the soft tissue is defined as the soft tissue contact surface. After implantation the wound edges can be directly adapted to the soft tissue contact surface thereby effecting a primary soft tissue closure to the implant.
- “Hydroxylated” in terms of the present invention means hydroxyl groups which are present in the outermost atomic layer of the implant surface. If the implant comprises titanium, zirconium, tantalum, niobium, hafnium or alloys thereof as well as chemically similarly reacting alloys, it is assumed that the surface of metal oxidizes spontaneously in air and water and that a reaction then takes place with water on the surface to form hydroxyl groups. This surface containing hydroxyl groups is referred to in the literature as a “hydroxylated” surface; cf. H. P. Boehm, Acidic and Basic Properties of Hydroxylated Metal Oxide Surfaces, Discussions Faraday Society, vol. 52, 1971, pp. 264-275. The same applies to ceramic surfaces (either on a ceramic implant or a metallic implant with a ceramic coating). A metal surface whose hydroxyl groups are covalently blocked, e.g. because of chemical modification, is not a “hydroxylated” surface in terms of the present invention.
- Silanated in terms of the present invention means that the implant surface is covered by a silanole or by an organo silane compound which has at least one free hydroxyl group. Examples of such organo silane compounds are XnSiR4-n, wherein X is selected from the group consisting of Cl, Br, I, F or OR, and R is selected from the group of lower alkyl groups, such as methyl, ethyl, propyl etc. Implants made of metal are preferably covered by a silanole, whereas implants made of ceramic are preferably covered by an organo silane compound. Implants made of metal can also be covered by an organo silan compound, and implants made of ceramic can also be covered by silanole.
- In a preferred embodiment of the present invention the soft tissue contact surface is completely hydroxylated. Such an implant showed good results in vivo and said implants are economically interesting and can be produced in a controlled process. In addition it has been shown that with the implants according to the present invention the healing process is improved, that is a good osteointegration as well as an excellent soft tissue integration is achieved. Therefore, the implants comprise a reduced risk of periimplantitis and as a consequence fewer implants will have to be replaced. Due to their purity, meaning that the soft tissue contact surface is free of organic compounds, the surface charge is better available. Therefore, the surface is hydrophilic, which results in an improved soft tissue integration. Therefore, they do not bear the risk of autoimmune reactions and other unwanted side effects.
- In a further embodiment of the present invention the soft tissue contact surface is roughened and hydroxylated. A roughened surface in terms of the present invention means a macroscopic texture of the surface which is obtained for example by sandblasting the soft tissue contact surface. It has been found that if the soft tissue contact surface is roughened and hydroxylated the blood coagulum is stabilized which accelerates the healing procedure.
- In a further embodiment of the present invention the soft tissue contact surface is smooth but hydroxylated. A smooth surface in terms of the present invention means a macroscopic texture of the surface which is obtained for example by machining or additional polishing, preferably by electropolishing the soft tissue contact surface. With a smooth surface the accumulation of plaque can be prevented or at least minimized, and such a soft tissue contact surface has outstanding wettability properties which is highly preferred.
- In a further embodiment of the present invention the bone contact surface and the soft tissue surface of the implant are both roughened, hydroxylated and hydrophilic or alternatively both smooth, hydroxylated and hydrophilic. Such implants are particularly easy to produce since the entire implant can be treated in the same way. This is a very big advantage and is based on the surprising finding that a hydroxylated, hydrophilic and roughened soft tissue surface of the implant shows improved soft tissue integration.
- In a further preferred embodiment of the present invention the soft tissue contact surface is hydrophilic. In terms of the present invention, the soft tissue contact surface is referred to as “hydrophilic” if it is freely accessible to the body fluid and not covered with foreign substances, for example substances with a hydrophobic action. Various volatile hydrocarbons are conventionally present in non-purified air. These are rapidly adsorbed in a thin layer by hydroxylated and hydrophilic surfaces, whereby such surfaces are no longer hydrophilic. Likewise, such a hydroxylated and hydrophilic surface can become hydrophobic if the hydroxyl groups present on the surface associate or react chemically e.g. with carbon dioxide present in the air or with organic solvents, such as methanol or acetone, introduced via the cleaning process. The hydrophilic properties of the soft tissue contact surface may result in a higher wettability when compared to an untreated soft tissue contact surface, which promotes formation of the soft tissue. Further, the charge on the surface is better available which may accelerate the formation of soft tissue attachment as well.
- The implants according to the invention preferably comprise mainly a metal selected from the group consisting of titanium, zirconium, niobium, hafnium or tantalum, preferably titanium or zirconium. Alternatively the implants comprise an alloy of metals selected from the group consisting of titanium, zirconium, niobium, hafnium or tantalum, preferably a binary titanium/zirconium alloy. Such implants, their nature and the metal materials used to produce them are known per se and are described for example in J. Black, G. Hastings, Handbook of Biomaterials Properties, pages 135-200, published by Chapman & Hall, London, 1998. From an aesthetic point of view, in particular in the front visible region, the soft tissue contact surface is preferably covered with a ceramic coating. This is for example obtainable by thermally spraying a ceramic material on the surface of a metallic core material such as described in U.S. Pat. No. 4,746,532. Also
EP 1 566 152 describes the coating of a dental implant with zirconia. Alternatively the implants may comprise a ceramic ring element, in particular in the soft tissue contact surface. Such ceramic coatings and ring elements comprise typically zirconia, aluminia, silica or mixtures thereof with possible further constituents, preferably they are made of zirconia. Alternatively the implant according to the present invention may be made of ceramic. - In a most preferred embodiment the implant according to the present invention is made of ceramic comprising a zirconium oxide based material. The cubic structure of zirconium oxide (zirconia) may be stabilized by metallic oxides at room temperature. Preferred metallic oxides are magnesium oxide, calcium oxide, oxides of the lanthanide group, preferably yttrium oxide. Depending on the content of said metallic oxides the cubic high temperature phase of zirconia can be stabilized fully or partly at room temperature (cubic stabilized zirconium oxide). Preferably zirconia is stabilized by yttrium oxide.
- The present invention also relates to the process for preparing the above disclosed implant.
- To obtain the hydroxylated surface, the soft tissue contact surface of the implant is preferably etched with an inorganic acid, an inorganic base, a mixture of inorganic bases or a mixture of inorganic acids. Particularly preferred are inorganic acids such as hydrofluoric acid, hydrochloric acid, sulfuric acid, nitric acid or a mixture of such acids. Preferably the implant is etched with a mixture of hydrochloric acid (conc.), sulphuric acid (conc.) and water in a weight ration of about 2:1:1. Alternatively the surface is activated with hydrochloric acid (conc.), hydrogen peroxide (conc.) and water in a weight ratio of about 1:1:5. The soft tissue contact surface is then washed with pure water in an inert atmosphere.
- A roughened soft tissue contact surface can be obtained by sandblasting said surface and keeping the surface in the resulting state if it is already hydroxylated and hydrophilic or converting the sandblasted surface to a hydroxylated and hydrophilic state in a separate process step.
- In particular, the roughened soft tissue contact surface can be produced by shot peening or sandblasting said surface and/or roughening it by using plasma technology, and then treating the mechanically roughened surface by an electrolytic or chemical process until a hydroxylated and hydrophilic surface is formed.
- The preferred procedure is to
-
- shot-peen the soft tissue contact surface of the implant and then etch it with diluted hydrofluoric acid at room temperature; or
- sandblast the soft tissue contact surface of the implant, e.g. with aluminium oxide particles having a mean size of 0.1-0.25 mm or 0.25-0.5 mm, and then treat it at elevated temperature with a hydrochloric acid/sulfuric acid mixture and wash it with pure distilled and carbon-free (CO2 and other carbons) water; or
- sandblast the soft tissue contact surface of the implant with coarse particles, e.g. with a mixture of particles as defined above, and then treat it with a hydrochloric acid/nitric acid mixture and wash it with pure distilled and carbon-free (CO2 and other carbons) water; or
- treat the soft tissue contact surface of the implant with a mixture of hydrochloric acid (conc.), hydrogen peroxide (conc.) and water in a weight ratio of about 1:1:5 and wash it with pure distilled and carbon-free (CO2 and other carbons) water; or
- roughen the soft tissue contact surface by using plasma technology and then hydroxylate it in a mixture of hydrochloric acid (conc.), hydrogen peroxide (conc.) and water in a weight ratio of about 1:1:5 and wash it with pure distilled and carbon-free (CO2 and other carbons) water; or
- treat the soft tissue contact surface by an electrolytic process, optionally after mechanical roughening of the surface, and then wash it with pure distilled and carbon-free (CO2 and other carbons) water; or
- treat the soft tissue contact surface of the implant by plasma cleaning or UV-treatment.
- These methods are known to those skilled in the art and are described for example in U.S. Pat. No. 5,071,351, The hydroxylated soft tissue contact surface of the implant is after such a treatment free of organic debris and has increased wettability. As a result, the implant becomes more intimately involved with the surrounding bone and tissue structure.
- Whatever the case may be, according to the invention the implant is not subjected to further aftertreatment, i.e. it is not treated with alcohol, acetone or any other organic solvent. In particular, said pure water contains neither carbon dioxide nor hydrocarbon vapours and especially no acetone and no alcohols like methanol or ethanol. However, it can contain special additives as described below. The “pure” water used for washing has preferably been distilled several times or prepared by reverse osmosis; the water has preferably been prepared in an inert atmosphere, i.e. under reduced pressure in a nitrogen or noble gas atmosphere, for example.
- Following these procedures, the
implant 1 obtained is left in pure water and stored in a closed vessel or acovering 2, as shown inFIG. 2 . In addition to water, the interior of the covering can containinert gases 3, for example nitrogen, oxygen or a noble gas such as argon. The implant obtained is preferably stored in pure water optionally containing selective additives, and in a covering which is practically impermeable to gases and liquids, especially to carbon oxides, the interior of the covering being devoid of any compounds capable of impairing the activity of the implant surface. - Alternatively, the implant could be placed in an inert gas atmosphere.
- The implant according to the invention, or at least its hydroxylated and hydrophilic surface, is preferably sealed in a gas-tight and liquid-tight covering, the interior of the covering being devoid of any compounds capable of impairing the biological activity of the implant surface. In this way it is avoided that the surface loses its activation fully or partially by means of air constituents, before the dental implant is applied. In a preferred embodiment there is a reducing atmosphere in the interior of the covering. This gas-tight and liquid-tight covering is preferably a heat-sealed ampoule made of glass, metal, a synthetic polymer or some other gas-tight and liquid-tight material, or a combination of these materials. The metal preferably takes the form of a thin sheet, it being possible for polymeric materials and metal sheets, as well as glass, to be combined together to form a suitable packaging in a manner known per se.
- Examples of suitable additives which can be incorporated in the pure water are cations and anions which already occur in the body fluid. In order to stabilize the positive charge the implant according to the present invention is preferably stored at a pH ranging from
pH 3 to 7, preferably 4 to 6. Alternatively it is also possible to store the implant at a pH ranging from pH 7 to 10 in order to stabilize the negative charge. Preferred cations are Na+, K+, Mg2+ and Ca2+. The preferred anion is Cl−. The total amount of said cations or anions ranges preferably from about 50 mM to 250 mM, particularly preferably from about 100 mM to 200 mM, and is preferably about 150 mM. If the covering contains divalent cations, especially Mg2+, Ca2+, Sr2+ and/or Mn2+, on their own or in combination with the above-mentioned monovalent cations, the total amount of divalent cations present preferably ranges from 1 mM to 20 mM. - The invention is explained below on the basis of figures and illustrative embodiments, without in any way limiting the invention to the embodiments shown.
-
FIG. 1 shows the different areas of an embodiment of an implant according to the invention that is the anchoring part of a two-part implant system. -
FIG. 2 shows an implant system according to the invention. - In accordance with one embodiment of the invention,
FIG. 1 shows animplant 1 which is preferably made of a tissue compatible metal or of an alloy of such a metal, in particular of titanium or of a titanium alloy. Alternatively the implant is made of ceramic, preferably of zirconia. Further it is possible that parts of the implant are made of metal and parts of the implant are made of ceramic, for example if the inner part is made of titanium and the outer part of the implant is made of ceramic. Theimplant 1 has a threadedsection 10 and a roundedlower end 15. At its upper end it has a slightly enlargedconical section 20. Saidimplant 1 is subdivided into a bone contact surface B and a soft tissue contact surface S. In the boundary area of these surfaces, there is a transition area B/S from bone contact surface B to soft tissue contact surface S, which transition area is assigned to both aforementioned areas. The question of whether this area, in the implanted state, is located in the bone or in the soft tissue depends on a large number of factors, for example the depth to which the implant is screwed, the tissue reaction, etc. The transition area has to be treated in the same way as the bone contact surface, in order to make sure, that in any case an optimal osteointegration is ensured. In the case ofimplants 1 made of titanium, the bone contact surface is preferably roughened, and even more preferred hydroxylated and hydrophilic as well. The soft tissue contact surface S is at least partially, preferably completely hydroxylated. In a preferred embodiment it is also roughened and/or hydrophilic. The soft tissue contact surface of an implant according to the present invention may be made of titanium, zirconium, tantalum, niobium, hafnium or alloys thereof as well as chemically similarly reacting alloys, but it is also possible that the implant has a ceramic coating which is hydroxylated. - The Examples which follow illustrate the invention.
- A common shape of dental implant in the form of a screw of diameter 4 mm and
length 10 mm was produced. The crude shape was obtained in a manner known per se by removing material from the cylindrical blank by turning on a lathe and milling. The bone contact surface as well as the soft tissue surface were then sandblasted with particles having a mean size of 0.25-0.5 mm as described in EP 0 388 575. The roughened surface was then treated for about five minutes at a temperature above 80° C. with an aqueous hydrochloric acid (conc.)/sulfuric acid (conc.) mixture having an HCl:H2SO4:H2O ratio of 2:1:1. The implant formed in this way was washed with pure water and then heat-sealed directly in a glass ampoule filled with pure water containing 150 mM Na+ ions, and the corresponding amount of Cl− anions. - To test the soft tissue integration, the above implants were placed in four female fox hounds. Each animal received 6 implants bilaterally in the upper jaw and 10 implants bilaterally in the lower jaw. The implants with a roughened hydroxylated soft tissue contact surface showed unexpectedly a much better soft tissue integration than comparable implants with an unhydroxylated surface. Soft tissue adhesion was seen already after a few days, the soft tissue integration was apparent within two weeks.
- A common shape of dental implant in the form of a screw of diameter 4 mm and
length 10 mm was produced. The crude shape was obtained in a manner known per se by removing material from the cylindrical blank by turning on a lathe and milling. The bone contact surface was then sandblasted with particles having a mean size of 0.25-0.5 mm, whereas the soft tissue contact surface has been electropolished. The sandblasted bone contact surface as well as the electropolished soft tissue contact surface were then treated for about five minutes at a temperature above 80° C. with an aqueous hydrochloric acid (conc.)/sulfuric acid (conc.) mixture having an HCl:H2SO4:H2O ratio of 2:1:1. The implant formed in this way was washed with pure water and then heat-sealed directly in a glass ampoule filled with pure water containing 150 mM Na+ ions, and the corresponding amount of Cl− anions. - To test the soft tissue integration, the above implants were placed in four female fox hounds. Each animal received 6 implants bilaterally in the upper jaw and 10 implants bilaterally in the lower jaw. The implants with a smooth hydroxylated soft tissue contact surface showed unexpectedly a much better soft tissue integration than comparable implants with an unhydroxylated surface. Soft tissue adhesion was seen already after a few days, the soft tissue integration was apparent within two weeks.
Claims (18)
1-19. (canceled)
20. Anchor part of a two-part implant system for attachment of artificial teeth, the anchor part being made of ceramic and comprising a base body having a bone contact surface and a soft tissue contact surface,
wherein the soft tissue contact surface is at least partially hydroxylated.
21. Anchor part according to claim 20 , wherein the soft tissue contact surface is completely hydroxylated.
22. Anchor part according to claim 20 , wherein the soft tissue contact surface is roughened.
23. Anchor part according to claim 20 , wherein the soft tissue contact surface is smooth.
24. Anchor part according to claim 22 , wherein the surface roughness of the soft tissue contact surface increases towards the bone contact surface continuously or stepwise.
25. Anchor part according to claim 20 , wherein the soft tissue contact surface is hydrophilic.
26. Anchor part according to claim 20 , wherein the soft tissue contact surface has the same macroscopic texture as the bone contact surface.
27. Anchor part according to claim 20 , wherein it is made of ceramic comprising a zirconium oxide based material.
28. Method for producing an anchor part of a two-part implant system in accordance with claim 20 , wherein the soft tissue contact surface is treated with a chemical etching procedure until a hydroxylated surface has been produced.
29. Method according to claim 28 , wherein the soft tissue contact surface is shot-blasted, sandblasted and/or roughened using plasma technology before treating with the chemical etching procedure.
30. Method according to claim 28 , wherein the chemical etching procedure is carried out with an inorganic acid or a blend of inorganic acids.
31. Method according to claim 30 , wherein said inorganic acid is selected from the group consisting of hydrofluoric acid, hydrochloric acid, sulphuric acid and mixtures thereof.
32. Method according to claim 30 , wherein said blend of inorganic acids is hydrochloric acid (conc.), hydrogen peroxide and water in a weight ratio of approximately 1:1:5.
33. Method according to claim 30 , wherein said blend of inorganic acids is a mixture of hydrochloric acid (conc.)/sulphuric acid (conc.)/water: 2/1/1.
34. Method according to claim 28 , wherein the surface is washed with pure water, which can additionally comprise additives, in an atmosphere that is inert in relation to the surface, and the surface, without subjection to a further treatment, is stored in an atmosphere that is inert in relation to the anchor part surface, and/or constantly in the presence of pure water, which can comprise additional additives.
35. Gas-tight and liquid-tight covering containing the anchor part according to claim 20 .
36. Method according to claim 34 , wherein the surface is stored in a covering which is impermeable for gases and liquids.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/474,604 US20150086943A1 (en) | 2006-02-28 | 2014-09-02 | Two-part implant with a hydroxylated soft tissue contact surface |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06004063.1 | 2006-02-28 | ||
EP06004063A EP1825830B1 (en) | 2006-02-28 | 2006-02-28 | Two-stage implant with a hydroxylated soft tissue contact surface |
US11/680,055 US20070202466A1 (en) | 2006-02-28 | 2007-02-28 | Two-Part Implant with a Hydroxylated Soft Tissue Contact Surface |
US14/474,604 US20150086943A1 (en) | 2006-02-28 | 2014-09-02 | Two-part implant with a hydroxylated soft tissue contact surface |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/680,055 Division US20070202466A1 (en) | 2006-02-28 | 2007-02-28 | Two-Part Implant with a Hydroxylated Soft Tissue Contact Surface |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150086943A1 true US20150086943A1 (en) | 2015-03-26 |
Family
ID=36297382
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/680,055 Abandoned US20070202466A1 (en) | 2006-02-28 | 2007-02-28 | Two-Part Implant with a Hydroxylated Soft Tissue Contact Surface |
US13/755,044 Abandoned US20130196289A1 (en) | 2006-02-28 | 2013-01-31 | Two-part implant with a hydroxylated soft tissue contact surface |
US14/474,604 Abandoned US20150086943A1 (en) | 2006-02-28 | 2014-09-02 | Two-part implant with a hydroxylated soft tissue contact surface |
US16/224,304 Active 2029-01-17 US11331167B2 (en) | 2006-02-28 | 2018-12-18 | Implant system with hydroxylated soft tissue contact surface |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/680,055 Abandoned US20070202466A1 (en) | 2006-02-28 | 2007-02-28 | Two-Part Implant with a Hydroxylated Soft Tissue Contact Surface |
US13/755,044 Abandoned US20130196289A1 (en) | 2006-02-28 | 2013-01-31 | Two-part implant with a hydroxylated soft tissue contact surface |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/224,304 Active 2029-01-17 US11331167B2 (en) | 2006-02-28 | 2018-12-18 | Implant system with hydroxylated soft tissue contact surface |
Country Status (5)
Country | Link |
---|---|
US (4) | US20070202466A1 (en) |
EP (3) | EP2292178A1 (en) |
JP (3) | JP2007229463A (en) |
AT (2) | ATE551966T1 (en) |
CA (1) | CA2575934A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3308808A1 (en) * | 2016-10-13 | 2018-04-18 | Straumann Holding AG | Process for preparing a body having an osseointegrative topography formed on its surface |
US11357600B2 (en) | 2014-12-16 | 2022-06-14 | Nobel Biocare Services Ag | Dental implant |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
KR100643090B1 (en) * | 2005-06-22 | 2006-11-10 | 주식회사 덴티움 | Abutment for implant |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
CA2655793A1 (en) | 2006-06-29 | 2008-01-03 | Boston Scientific Limited | Medical devices with selective coating |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
EP2068757B1 (en) | 2006-09-14 | 2011-05-11 | Boston Scientific Limited | Medical devices with drug-eluting coating |
WO2008034048A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprosthesis with biostable inorganic layers |
WO2008034013A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
WO2008034031A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
CA2663271A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
WO2008036548A2 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
CA2671348A1 (en) | 2006-12-22 | 2008-07-03 | Thommen Medical Ag | Dental implant and method for the production thereof |
WO2008083190A2 (en) | 2006-12-28 | 2008-07-10 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making same |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) * | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
WO2009018340A2 (en) | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
EP2185103B1 (en) | 2007-08-03 | 2014-02-12 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US20110311946A1 (en) * | 2008-03-05 | 2011-12-22 | Irena Sailer | Mutallic dental implants and prosphetic appliance having colored ceramic surfaces |
JP5581311B2 (en) | 2008-04-22 | 2014-08-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | MEDICAL DEVICE HAVING INORGANIC MATERIAL COATING AND MANUFACTURING METHOD THEREOF |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
JP5207480B2 (en) * | 2008-05-30 | 2013-06-12 | 株式会社ナントー精密 | Implant body, manufacturing method thereof and dental implant |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
EP2403546A2 (en) | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
WO2011119573A1 (en) | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8641418B2 (en) | 2010-03-29 | 2014-02-04 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
WO2011120694A2 (en) * | 2010-03-31 | 2011-10-06 | Straumann Holding Ag | Dental implant having different surface structure regions |
DE102011050335A1 (en) | 2011-05-13 | 2012-11-15 | Microceram Gmbh | Process for the treatment of ceramic surfaces and ceramic implants based on zirconium oxide |
WO2014138135A1 (en) * | 2013-03-04 | 2014-09-12 | EdMiDent, LLC | Intraosseous dental implant support mechanism |
ES2853934T3 (en) * | 2013-06-07 | 2021-09-20 | Straumann Holding Ag | Dental implant |
CH708833A1 (en) * | 2013-11-14 | 2015-05-15 | Qvanteq Ag | Implant with improved surface properties. |
CH708834A1 (en) * | 2013-11-14 | 2015-05-15 | Qvanteq Ag | Implant with improved surface properties. |
JP2018108118A (en) * | 2015-03-31 | 2018-07-12 | 国立大学法人東北大学 | Production method of device for implant and device for implant |
GB201711483D0 (en) * | 2017-07-17 | 2017-08-30 | Rishon Mor Invest Ltd | Dental implant |
KR101972991B1 (en) | 2017-07-31 | 2019-08-16 | (주) 타우피엔유메디칼 | Equipment for the treatment of tricuspid regurgitation |
KR101965637B1 (en) | 2017-07-31 | 2019-04-03 | (주) 타우피엔유메디칼 | A device for the treatment of tricuspid regurgitation in the pulmonary artery |
DE102017009251B3 (en) | 2017-10-05 | 2018-11-29 | Ljubinko Petrovic | Bone implant with a ceramic anchoring part and a manufacturing method therefor |
DE102017012134B3 (en) | 2017-12-28 | 2019-03-07 | Ljubinko Petrovic | Bone implant with an anchoring part made of a biocompatible plastic |
CN112869897B (en) * | 2021-01-14 | 2022-01-25 | 南京医科大学附属口腔医院 | Zirconia implant surface treatment method |
US20230190417A1 (en) * | 2021-12-20 | 2023-06-22 | feras Al rezk | Dental implant platform and connection |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030104338A1 (en) * | 2001-12-03 | 2003-06-05 | Richard Cottrell | Modified dental implant fixture |
WO2003045268A1 (en) * | 2001-11-30 | 2003-06-05 | Michael Gahlert | Ceramic dental implant |
US20040210309A1 (en) * | 2001-10-11 | 2004-10-21 | Denzer Alain J | Osteophilic implants |
US20050064007A1 (en) * | 2002-01-21 | 2005-03-24 | Steinemann Samuel G. | Surface-modified implants |
US20050113834A1 (en) * | 2003-10-27 | 2005-05-26 | Michael Breitenstien | Implant with a ceramic coating, and method for ceramic coating of an implant |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797113A (en) * | 1970-06-01 | 1974-03-19 | Vitredent Corp | Dental implant |
JPH0669482B2 (en) | 1985-08-08 | 1994-09-07 | 住友化学工業株式会社 | Intraosseous implant manufacturing method |
US5071351A (en) | 1986-07-02 | 1991-12-10 | Collagen Corporation | Dental implant system |
FR2623709A1 (en) * | 1987-12-01 | 1989-06-02 | Benhaim Lucien | 2nd generation endo-osseus tubular implant |
DE3831487A1 (en) * | 1988-09-16 | 1990-03-29 | Gestra Ag | THERMALLY CONTROLLED VALVE |
FR2636709B1 (en) * | 1988-09-16 | 1991-07-26 | Gestra Ag | THERMO-CONTROLLED VALVE, ESPECIALLY CONDENSATE DRAIN |
EP0388575A1 (en) | 1989-03-23 | 1990-09-26 | Neomat Ag | Snow guard |
JP2858126B2 (en) | 1989-06-30 | 1999-02-17 | 京セラ株式会社 | Biological implant material and its manufacturing method |
WO1991003213A1 (en) * | 1989-08-30 | 1991-03-21 | Tdk Corporation | Artificial dental root |
SE9203184D0 (en) * | 1992-10-28 | 1992-10-28 | Astra Ab | DENTAL IMPLANT |
JPH06133992A (en) * | 1992-10-29 | 1994-05-17 | Nikon Corp | Implant for living body |
US5642996A (en) * | 1993-10-20 | 1997-07-01 | Nikon Corporation | Endosseous implant |
JPH07328038A (en) * | 1994-06-15 | 1995-12-19 | Nikon Corp | Intraosseous implant |
JPH07328037A (en) * | 1994-06-15 | 1995-12-19 | Nikon Corp | Intraosseous implant |
US5571017A (en) * | 1994-10-05 | 1996-11-05 | Core-Vent Corporation | Selective surface, externally-threaded endosseous dental implant |
JPH08257110A (en) * | 1995-03-28 | 1996-10-08 | Nikon Corp | Endosteal implant an manufacture thereof |
JP3803140B2 (en) * | 1995-07-07 | 2006-08-02 | 株式会社アドバンス | Dental implant and method for manufacturing dental implant |
DE59812307D1 (en) * | 1997-06-02 | 2004-12-30 | Straumann Inst Ag | HOLDING ELEMENT FOR AN IMPLANT AND AMPULLE FOR STORING THE IMPLANT |
EP1023910A1 (en) * | 1999-01-29 | 2000-08-02 | Institut Straumann AG | Preparation of osteophilic surfaces for metallic prosthetic devices anchorable to bone |
WO2000044305A1 (en) * | 1999-01-29 | 2000-08-03 | Institut Straumann Ag | Osteophilic implants |
US6095817A (en) * | 1999-02-24 | 2000-08-01 | Sulzer Calcitek Inc. | Dental implant having multiple textured surfaces |
JP3072373B1 (en) * | 1999-07-05 | 2000-07-31 | 工業技術院長 | Artificial dental root having pollutant, germ adhesion suppressing function and acid resistance, and manufacturing method |
JP2001190570A (en) * | 2000-01-14 | 2001-07-17 | Science & Tech Agency | Artificial tooth root |
AU2001270206A1 (en) * | 2000-06-28 | 2002-01-08 | Sheldon Lerner | Dental implant |
CH694935A5 (en) * | 2000-07-26 | 2005-09-30 | Straumann Holding Ag | Oberflaechenmodifizierte implants. |
WO2002040073A1 (en) | 2000-11-20 | 2002-05-23 | Université De Genève | Endosseous implant |
JP2002369830A (en) * | 2001-06-14 | 2002-12-24 | Advance Co Ltd | Dental implant |
US20030087217A1 (en) * | 2001-11-07 | 2003-05-08 | Coatoam Gary W. | Dental implant method & apparatus |
ATE347329T1 (en) * | 2003-02-05 | 2006-12-15 | Straumann Holding Ag | EXTENSION PIECE FOR A DENTAL IMPLANT, TRANSFER AID AND METHOD FOR CREATING A BASE FOR A RETENTION ELEMENT |
US7112063B2 (en) * | 2003-08-11 | 2006-09-26 | Ronald A Bulard | Dental implant system |
EP1529498B9 (en) * | 2003-11-05 | 2014-09-10 | Dentsply Implants Manufacturing GmbH | Multi part non metal implant |
SE526749C2 (en) * | 2003-12-11 | 2005-11-01 | Nobel Biocare Ab | Dental implant device and method for its preparation |
DE102004008608A1 (en) | 2004-02-21 | 2005-09-08 | Hartmann, Hans-Jürgen, Dr. | Dental implant |
JP2005270528A (en) * | 2004-03-26 | 2005-10-06 | Tokyo Denki Univ | Artificial tooth root |
US20080014556A1 (en) * | 2004-06-04 | 2008-01-17 | Stefan Neumeyer | Tooth Implant |
DE102004027959B4 (en) | 2004-06-08 | 2009-11-12 | Feith, Johan, Dr. | Dental implant and method for its production |
-
2006
- 2006-02-28 AT AT09014662T patent/ATE551966T1/en active
- 2006-02-28 EP EP10010968A patent/EP2292178A1/en not_active Withdrawn
- 2006-02-28 EP EP06004063A patent/EP1825830B1/en not_active Revoked
- 2006-02-28 EP EP09014662A patent/EP2160998B1/en not_active Revoked
- 2006-02-28 AT AT06004063T patent/ATE516767T1/en not_active IP Right Cessation
-
2007
- 2007-01-26 CA CA002575934A patent/CA2575934A1/en not_active Abandoned
- 2007-02-23 JP JP2007044391A patent/JP2007229463A/en active Pending
- 2007-02-28 US US11/680,055 patent/US20070202466A1/en not_active Abandoned
-
2013
- 2013-01-31 US US13/755,044 patent/US20130196289A1/en not_active Abandoned
- 2013-04-30 JP JP2013095677A patent/JP6029105B2/en active Active
-
2014
- 2014-06-11 JP JP2014120751A patent/JP6211466B2/en active Active
- 2014-09-02 US US14/474,604 patent/US20150086943A1/en not_active Abandoned
-
2018
- 2018-12-18 US US16/224,304 patent/US11331167B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040210309A1 (en) * | 2001-10-11 | 2004-10-21 | Denzer Alain J | Osteophilic implants |
WO2003045268A1 (en) * | 2001-11-30 | 2003-06-05 | Michael Gahlert | Ceramic dental implant |
US20050106534A1 (en) * | 2001-11-30 | 2005-05-19 | Michael Gahlert | Ceramic dental implant |
US20030104338A1 (en) * | 2001-12-03 | 2003-06-05 | Richard Cottrell | Modified dental implant fixture |
US20050064007A1 (en) * | 2002-01-21 | 2005-03-24 | Steinemann Samuel G. | Surface-modified implants |
US20050113834A1 (en) * | 2003-10-27 | 2005-05-26 | Michael Breitenstien | Implant with a ceramic coating, and method for ceramic coating of an implant |
Non-Patent Citations (1)
Title |
---|
Machine translation of WO2003045268. * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357600B2 (en) | 2014-12-16 | 2022-06-14 | Nobel Biocare Services Ag | Dental implant |
US11918434B2 (en) | 2014-12-16 | 2024-03-05 | Nobel Biocare Services Ag | Dental implant |
EP3308808A1 (en) * | 2016-10-13 | 2018-04-18 | Straumann Holding AG | Process for preparing a body having an osseointegrative topography formed on its surface |
EP3685865A1 (en) * | 2016-10-13 | 2020-07-29 | Straumann Holding AG | Process for preparing a body having an osseointegrative topography formed on its surface |
US10864062B2 (en) | 2016-10-13 | 2020-12-15 | Straumann Holding Ag | Process for preparing a body having an osseointegrative topography formed on its surface |
Also Published As
Publication number | Publication date |
---|---|
CA2575934A1 (en) | 2007-08-28 |
JP2014158984A (en) | 2014-09-04 |
JP6211466B2 (en) | 2017-10-11 |
JP2007229463A (en) | 2007-09-13 |
US20190117344A1 (en) | 2019-04-25 |
EP2160998B1 (en) | 2012-04-04 |
ATE551966T1 (en) | 2012-04-15 |
EP2292178A1 (en) | 2011-03-09 |
EP2160998A1 (en) | 2010-03-10 |
US11331167B2 (en) | 2022-05-17 |
EP1825830A1 (en) | 2007-08-29 |
ATE516767T1 (en) | 2011-08-15 |
EP1825830B1 (en) | 2011-07-20 |
JP2013173000A (en) | 2013-09-05 |
JP6029105B2 (en) | 2016-11-24 |
US20070202466A1 (en) | 2007-08-30 |
US20130196289A1 (en) | 2013-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11331167B2 (en) | Implant system with hydroxylated soft tissue contact surface | |
US8029283B2 (en) | Abutment with a hydroxylated surface | |
US20070202464A1 (en) | One-Part Implant with a Hydroxylated Soft Tissue Contact Surface | |
US11786342B2 (en) | Surface area of a ceramic body and ceramic body | |
JP3735649B2 (en) | Intraosseous dental implant | |
CA2360580C (en) | Osteophilic implants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |